Myelofibrosis: State-of-the-Art Clinical Advances and Therapeutic Strategies From JAK Inhibition Into the Future

Learn strategies for selecting the optimal JAK inhibitor–based therapy from the experts to optimize the care of patients with myelofibrosis through an on-demand webcast with accompanying slides and a ClinicalThought commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline